arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Novavax, Inc.

NVAX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$9.49
▼ -6.9% Today
as of Jun 7, 07:23 ET
Last 30 days +19.82% Apr 28 → Jun 05
$7.67 $8.59 $9.51 $10.42 $11.34 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$9.97
High
$10.13
Low
$9.26
Volume
$5M
Avg Vol
$5M
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$11.97
52w Low
$6.13
Div Yield
Shares Out
$164M

Overview

52-week range
$6.13
$12
58% of range
Avg surprise (last 2)
+194.3%
Avg reaction (last 2)
+13.7%
100% positive
Latest IV / EM
102%
EM ±9.5% · $10 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.26$-0.21$0.84$1.88$2.93 Actual $0.58Actual $-1.26Actual $-1.05Actual $0.99Actual $-0.76Actual $2.93Est $0.71Actual $0.62Actual $-1.25Actual $-0.06Est $-0.25 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-202M$23M$249M$474M$700M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.06 $-0.25 +76.0% -102.0% +15.6% earnings
Tue Sep 30, 2025Sep 2025 $-1.25 financials
Mon Jun 30, 2025Jun 2025 $0.62 financials
Thu May 8, 2025Mar/2025 $2.93 $0.71 +312.7% +11.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.76 financials
Sun Jun 30, 2024Jun 2024 $0.99 financials
Sun Mar 31, 2024Mar 2024 $-1.05 financials
Sat Sep 30, 2023Sep 2023 $-1.26 financials
Fri Jun 30, 2023Jun 2023 $0.58 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$140M$70M$239M$667M$85M$415M
Cost of revenue$31M$21M$15M$14M$61M$46M
Gross profit
Operating income$-15M$-178M$101M$516M$-134M$161M
Net income$-9M$-202M$107M$519M$-121M$162M
EPS (diluted)$-0.06$-1.25$0.62$2.93$-0.76$0.99

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$228M$241M$268M$254M$263M$530M$574M$680M
Inventory$11M$12M$14M$10M$10M$9M$9M$9M
Total current assets$851M$978M$975M$920M$868M$1.13B$1.10B$1.20B
Total assets$1.04B$1.18B$1.18B$1.34B$1.29B$1.56B$1.71B$1.82B
Long-term debt$291M$244M
Total liabilities$1.19B$1.30B$1.34B$1.30B$1.37B$2.18B$2.24B$2.25B
Total equity$-145M$-128M$-157M$38M$-76M$-624M$-526M$-432M

Implied volatility — last 90 days

96%99%101%104%106% Jun 07 — IV 102% · EM ±9.5%

Sector peers